| GO |
B_2_1 |
GO:0015453 |
oxidoreduction-driven active transmembrane transporter activity |
4/18 |
68/18737 |
4.67162820529782e-07 |
4.297897948874e-05 |
2.11452645081902e-05 |
COX6B1/COX7B/NDUFB3/NDUFS6 |
4 |
| GO |
B_2_1 |
GO:1901293 |
nucleoside phosphate biosynthetic process |
6/19 |
321/18986 |
5.02432638176109e-07 |
4.4732712302131e-06 |
2.76380602324379e-06 |
ATP5MJ/ATP5MK/NDUFAB1/NDUFB3/NDUFS6/STOML2 |
6 |
| GO |
B_2_1 |
GO:0042776 |
proton motive force-driven mitochondrial ATP synthesis |
4/19 |
68/18986 |
5.60069125188296e-07 |
4.83059620474906e-06 |
2.98457889080605e-06 |
NDUFAB1/NDUFB3/NDUFS6/STOML2 |
4 |
| hallmark |
B_2_1 |
HALLMARK_OXIDATIVE_PHOSPHORYLATION |
HALLMARK_OXIDATIVE_PHOSPHORYLATION |
6/9 |
200/4384 |
6.27233728913025e-07 |
3.13616864456513e-06 |
1.98073809130429e-06 |
COX6B1/COX7B/HSD17B10/NDUFAB1/NDUFB3/NDUFS6 |
6 |
| KEGG |
B_2_1 |
hsa05014 |
Amyotrophic lateral sclerosis |
7/14 |
371/8541 |
7.26937748394812e-07 |
3.75584503337319e-06 |
2.04052701303807e-06 |
COX6B1/COX7B/NDUFAB1/NDUFB3/NDUFS6/PSMA5/PSMB3 |
7 |
| GO |
B_2_1 |
GO:0015980 |
energy derivation by oxidation of organic compounds |
6/19 |
356/18986 |
9.19894418539828e-07 |
7.69366240960583e-06 |
4.7535213972393e-06 |
COX6B1/COX7B/NDUFAB1/NDUFB3/NDUFS6/STOML2 |
6 |
| WikiPathways |
B_2_1 |
WP4396 |
Nonalcoholic fatty liver disease |
5/13 |
154/8836 |
1.73289663801153e-06 |
2.25276562941499e-05 |
1.0944610345336e-05 |
COX6B1/COX7B/NDUFAB1/NDUFB3/NDUFS6 |
5 |
| KEGG |
B_2_1 |
hsa00190 |
Oxidative phosphorylation |
5/14 |
138/8541 |
1.82381287629665e-06 |
8.07688559502801e-06 |
4.38812120612727e-06 |
COX6B1/COX7B/NDUFAB1/NDUFB3/NDUFS6 |
5 |
| reactome |
B_2_1 |
R-HSA-611105 |
Respiratory electron transport |
5/17 |
158/11146 |
2.89719690548609e-06 |
0.00042588794510645 |
0.0001768814952823 |
COX6B1/COX7B/NDUFAB1/NDUFB3/NDUFS6 |
5 |
| KEGG |
B_2_1 |
hsa04932 |
Non-alcoholic fatty liver disease |
5/14 |
157/8541 |
3.44857902981944e-06 |
1.33632437405503e-05 |
7.26016637856724e-06 |
COX6B1/COX7B/NDUFAB1/NDUFB3/NDUFS6 |
5 |